JCVI backs HPV jab for boys

24th July 2018 Uncategorised 0

The Lancet has published full results of a Phase II trial showing the benefit of Lilly’s JAK inhibitor Olumiant in the treatment of global systemic lupus erythematosus (SLE).

More: JCVI backs HPV jab for boys
Source: News